Clinical Results with Recombinant Human Interleukin-3

References

• Groopman J E, Molina J M, Scadden D T. Hematopoietic growth factors. Biology and clinical applications. N Engl J Med 1989; 321: 149–1459
   Google Scholar
• Yang Y C, Ciarletta A B, Temple P A. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 1986; 47: 3–10
   PubMed Web of Science ®Google Scholar
• Yang Y C, Kovacic S, Kriz R. The human genes for GM-CSF and IL-3 are closely linked in tandem on chromosome 5. Blood 1988; 71: 958–961
   PubMed Web of Science ®Google Scholar
• Niemeyer C M, Sieff C A, Mathey-Prevot B. Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. Blood 1989; 73: 945–951
   PubMed Web of Science ®Google Scholar
• Wodnar-Filipowicz A, Heusser C H, Moroni C. Production of the hematopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor mediated activation. Nature 1989; 339: 150–152
   PubMed Web of Science ®Google Scholar
• Oster W, Lindemann A, Mertelsmann R, Herrmdnn F. Production of macrophage-, granulocyte-, granulocyte-macrophage-and multi-colony-stimulating factor by pcripherdl blood cells. Eur J Immunol 1989; 19: 543–547
   PubMed Web of Science ®Google Scholar
• Leary A G, Yang Y C, Clark S C. Recombinant gibbon in-terleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture; comparison with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1987; 70: 1343–1348
   PubMed Web of Science ®Google Scholar
• Saeland S, Caux C, Favre C. Effects of recombinant human interleukin 3 in CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. Blood 1988; 72: 1580–1588
   PubMed Web of Science ®Google Scholar
• Sonoda Y, Yang Y C, Wong G G. Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: Interleukin-3 and granulocyte-macrophage-colony-stim-ulating factor are specific for early development stages. Roc Natl Acad Sci (USA) 1988; 85: 4360–4363
   PubMed Web of Science ®Google Scholar
• Rothenberg M E, Owen WF, Jr, Silberstein D S. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 1988; 81: 1986–1992
   PubMed Web of Science ®Google Scholar
• Lopez A F, Dyson P G, To L B. Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness in differentiation in the neutrophilic myeloid series. Blood 1988; 72: 1797–1804
   PubMed Web of Science ®Google Scholar
• Cannistra S A, Vellenga E, Groshek P. Human granulocyte-monocyte colony-stimulating factor and interleukin-3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 1988; 71: 672–676
   PubMed Web of Science ®Google Scholar
• Chen B DM, Clark C R. Interleukin-3 (IL-3) regulates the in vitro proliferation of both blood monocytes and peritoneal exudate macrophages: synergism between a macrophage lineage-specific colony-stimulating factor (CSF-I) and IL-3. J lmmunol 1986; 137: 563–570
   PubMed Web of Science ®Google Scholar
• Kurimoto Y, De Weck A L, Dahinden C A. Interleukin-3 dependent mediator release in basophils triggered by C5a. I Exp Med 1989; 170: 467–479
   PubMed Web of Science ®Google Scholar
• Valent P, Besemer J, Muhm M. Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci (USA) 1989; 86: 5542–5546
   PubMed Web of Science ®Google Scholar
• Uckun F M, Gesner T G, Song C W. Leukemic B cell precursors express functional receptors for interleukin-3. Blood 1989; 73: 1533–541
   Google Scholar
• Londei M, Verhoef A, De Berardinis P. Definition of a population of CD4– CD8– T cells that express the alpha-beta T-cell receptor and respond to interleukins 2, 3, and 4. Proc Natl Acad Sci (USA) 1989; 86: 8502–8506
   PubMed Web of Science ®Google Scholar
• Lopez A F, To L B, Yang Y-C. Stimulation of proliferation, differentiation and function of human cells by primate interleukin-3. Proc Natl Acad Sci (USA) 1987; 84: 2761–2765
   PubMed Web of Science ®Google Scholar
• Emerson S G, Yang Y C, Clark S C, Long M W. Human recombinant granulocyte-macrophage colony-stimulating factors and interleukin 3 have overlapping but distinct hematopoietic activities. J Clin Invest 1988; 82: 1282–1287
   PubMed Web of Science ®Google Scholar
• Bruno R, Briddell R, Hoffman R. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. Exp Hematol 1988; 16: 371–377
   PubMed Web of Science ®Google Scholar
• Lu L, Briddell R A, Graham C D. Effect of recombinant and purified human haematopoietic growth factors on in vitro colony formation by enriched populations of human megakaryocyte progenitor cells. Br J Haematol 1988; 70: 149–156
   PubMed Web of Science ®Google Scholar
• Teramura M, Katahira J, Setal Hoshino. Clonal growth of human megakaryocyte progenitors in serum-free cultures: effect of re-combinant human interleukin-3. Exp Hematol 1988; 162: 343–848
   Google Scholar
• Metcalf D, Begley C G, Johnson G R. Effects of purified bacterially synthesized murine mutli-CSF (IL-3) on hemato-poiesis in normal adult mice. Blood 1986; 68: 46–57
   PubMed Web of Science ®Google Scholar
• Lord B I, Molineaux G, Testa N G. The kinetic response of haemopoietic precursor cells. in vivo. to highly purified recom-binant interleukin-3. Lymphokine Res 1986; 5: 97–104
   PubMedGoogle Scholar
• Kindler V, Thorens B, De Kossodo S. Stimulation of he-matopoiesis in vivo by recombinant bacterial murine interleukin 3. Proc Natl Acad Sci (USA) 1986; 83: 1001–1005
   PubMed Web of Science ®Google Scholar
• Broxmeyer H E, Williams D, Hangoc G. Synergistic mye-lopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1. recombinant murine interleukin-3, and recombinant murine gran-ulocytelmacrophage colony-stimulating factor. Proc Natl Acad Sci (USA) 1987; 84: 3871–3875
   PubMed Web of Science ®Google Scholar
• Donahue R E, Seehra J, Metzger M. Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates. Science 1988; 241: 1820–1823
   PubMed Web of Science ®Google Scholar
• Krumwieh D, Seiler F R. In vivo effects of recombinant colony stimulating factors on hematopoiesis in cynamolgus monkeys. Transplant Proc 1989; 21: 379–383
   PubMedGoogle Scholar
• Mayer P, Valent P, Schmidt G. The in vivo effect of recombinant human interleukin-3: demonstration of basophil differentiation factor. histamine-producing activity and priming of GM-CSF-responsive progenitors in nonhuman primates. Blood 1989; 74: 613–621
   PubMed Web of Science ®Google Scholar
• Ulich T R, Del Castillo J, Busser K. Acute in vivo effects of IL-3 alone and in combination with IL-6 on the blood cells of the circulation and bone marrow. Am J Pathol 1989; 135: 663–670
   PubMed Web of Science ®Google Scholar
• Broxmeyer H E, Williams D E, Cooper S. Comparative effects in vivo of recombinant murine interleukin 3. natural murine colony-stimulating factor-I, and recombinant murine granulo-cyte-macrophage colony-stimulating factor on myelopoiesis in mice. J Clin Invest 1987; 79: 721–730
   PubMed Web of Science ®Google Scholar
• Williams D E, Hangoc G, Cooper S. The effects of purified recombinant murine interleukin-3 and/or purified natural murine CSF-I in vitro on the proliferation of murine high-and low-proliferative potential colony-forming cells: demonstration of in vivo synergism. Blood 1987; 70: 401–403
   PubMed Web of Science ®Google Scholar
• Metcalf D, Begley C G, Johnson G R. Hemopoietic effects of purified bacterially synthesized mutli-CSF in normal and marrow-transplanted mice. Immunology 1986; 172: 158–167
   Google Scholar
• Ceissler K, Valent P, Mayer P. Recombinant human interleukin-3 expands the pool of circulating hemopoietic stem cells in primates—synergism with recombinant human granulocyte/ macrophage colony-stimulating factor. Blood 1990; 75: 2305–2310
   PubMed Web of Science ®Google Scholar
• Ganser A, Lindemann A, Seipelt G. Effect of recombinant human interleukin-3 in patients with normal hematopoiesis and in paitents with bone marrow failure. Blood 1990; 76: 666–676
   PubMed Web of Science ®Google Scholar
• Ganser A, Seipelt G, Lindemann A. Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood 1990; 76: 455–462
   PubMed Web of Science ®Google Scholar
• Ganser A, Lindemann A, Seipelt G. Effects of recombinant human interleukin-3 in aplastic anemia. Blood 1990; 76: 1287–1292
   PubMed Web of Science ®Google Scholar
• Gillis G, Urdal D L, Clergenger W. Production of recombinant human colony-stimulating factors in yeast. Behring lnst Mitt 1988; 83: l–7
   Google Scholar
• Lindemann A, Ganser A, Henmann F. Biological effects of recombinant human interleukin-3 in vivo. J Clin Oncol 1991; 9: 2120–2127
   PubMed Web of Science ®Google Scholar
• Migliaccio A R, Migliaccio G, Adamson J W. Effect of recombinant hemopoietic growth factors on proliferation of human marrow progenitor cells in serum-deprived liquid culture. Blood 1988; 72: 1387–1392
   PubMed Web of Science ®Google Scholar
• Ganser A, Lindemann A, Seipelt G. Clinical effects of recombinant human interleukin-3. Am J Clin Oncol (CCT) 1991; 14: 51–63, SupplI I
   PubMed Web of Science ®Google Scholar
• Tadmori W, Feingenh D, Clark SC., Choi Y S. Human recombinant IL-3 stimulates B cell differentiation. J Immunol 1989; 142: 1950–1955
   PubMed Web of Science ®Google Scholar
• Falk S, Seipelt G, Ganser A. Bone marrow findings after treatment with recombinant human interleukin-3. Am J Clin Pathol 1991; 95: 355–362
   PubMed Web of Science ®Google Scholar
• Ottmann O G, Ganser A, Seipelt G. Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. Blood 1990; 76: 1494–1502
   PubMed Web of Science ®Google Scholar
• Groopman J E, Mitsuyasu R T, DeLeo M J. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl JMed 1987; 317: 593–598
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Keating M, LeMaistre A. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 1987; 317: 1545–1552
   PubMed Web of Science ®Google Scholar
• Antin J H, Smith B R, Holmes W., Rosenthal D S. Phase I/ II study of recombinant human granulocyte-macrophage colony-stimukiting factor in aplastic anemia and myelodysplastic syndrome. Blood 1988; 72: 705–713
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Buescher S, Broxmeyer H E. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. N Engl J Med 1988; 319: 1628–1634
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S, Buescher S, LeMaistre A. Stimulation of hematopoiesis in patients with malignancy by reconibinant human granulocyte-macrophage colony-stimulating factor. Blood 1988; 72: 134–141
   PubMed Web of Science ®Google Scholar
• Ganser A, Voelkers B, Greher J. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes—a phase I/II study. Blood 1989; 73: 31–37
   PubMed Web of Science ®Google Scholar
• Thompson J A, Lee D J, Kidd P. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic sydrome: toxicity. pharmacokinetics and hematologi-cal effects. J Clin Oncol 1989; 7: 629–637
   PubMed Web of Science ®Google Scholar
• Henmann F, Lindemann A, Klein H. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts. Leukemia 1988; 3: 355–388
   Google Scholar
• Negrin R S, Haeuber D H, Nagler A. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phasel-II trial. Ann Intern Med 1989; 110: 976–984
   PubMed Web of Science ®Google Scholar
• Glaspy J A, Baldwin G C, Robertson P A. Therapy for neu-tropenia in hairy cell leukemia with recombinant human granu-locyte colony-stimulating factor. Ann Intern Med 1988; 109: 789–795
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Okabe T, Ozawa K. Treatment of myelo-dysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A preliminary Report. Am J Med 1989; 86: 178–182
   PubMed Web of Science ®Google Scholar
• Jakubowski A A, Souza L, Kelly F. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neu-tropenia. N Engl J Med 1989; 320: 38–42
   PubMed Web of Science ®Google Scholar
• Bonilla M A, Gillio A P, Ruggeiro M. Effects of recombinant human granulocyte colony-stimulating factor in patients with congenital agranulocytosis. N Engl J Med 1989; 320: 1574–1580
   PubMed Web of Science ®Google Scholar
• Welte K, Zeidler C, Reiter A. Differenital effects of gran-ulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neu-tropenia. Blood 1990; 75: 1056–1063
   PubMed Web of Science ®Google Scholar
• Tricot G J, Lauer R C, Appelbaum F R. Management of the myelodysplastic syndromes. Semin Oncol 1987; 14: 444–453
   PubMed Web of Science ®Google Scholar
• Speck B, Gratwohl A, Nissen C. Treatment of severe aplastic anemia. Exp Hematol 1986; 14: 126
   PubMed Web of Science ®Google Scholar
• Camitta B M, Thomas E D, Nathan D G. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979; 53: 504–514
   PubMed Web of Science ®Google Scholar
• Merget R D, Maurer A B, Koch U. Histamine release from basophils after in vivo application of recombinant human inter-leukin-3 in man. Int Arch Aller Appl Immunol 1990; 92: 366–374
   PubMedGoogle Scholar
• Delwel R, Dorssers L, Touw I. Human recombinant mul-tilineage colony-stimulating factor: stimulator of acute myelocytic leukemia progenitor cells in vitro. Blood 1987; 70: 333–336
   PubMed Web of Science ®Google Scholar
• Wagemaker G, Van Gils F CJM, Burger H. Highly increased production of bone marrow derived blood cells by administration of homologous interleukin-3 to rhesus monkeys. Blood 1990; 76: 2235–2241
   PubMed Web of Science ®Google Scholar